Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hemogenyx Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price



Market Capitalization

£21 M


CreditSafe Score

Score changed on May 20, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

GBPFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022
Gross profit91.0K213.0K85.0K172.0K
Operating expense total1.6M1.6M2.1M2.7M5.0M
Depreciation and amortization52.0K94.0K106.0K126.0K564.0K
Interest income4.0K14.0K3.0K
Interest expense1.0K31.0K33.0K2.6M
Pre tax profit(1.6M)(1.5M)(2.1M)(5.1M)(4.0M)
Income tax expense(44.0K)(35.0K)
Net Income(1.5M)(1.5M)(2.1M)(5.1M)(4.0M)

Footer menu